Skinvisible, Inc. (SKVI)

OTCMKTS · Delayed Price · Currency is USD
0.400
+0.190 (90.39%)
Mar 9, 2026, 3:38 PM EST
44.77%
Market Cap 2.03M
Revenue (ttm) 20.00K
Net Income (ttm) -490.91K
Shares Out 5.40M
EPS (ttm) -0.09
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3
Average Volume 3,161
Open 0.400
Previous Close 0.210
Day's Range 0.400 - 0.400
52-Week Range 0.081 - 0.900
Beta 1.60
RSI 49.91
Earnings Date Feb 13, 2026

About Skinvisible

Skinvisible, Inc. focuses on the development, manufacture, and sale of topical, transdermal, and mucosal polymer-based delivery system technologies and formulations for use in pharmaceutical, over-the-counter, personal skincare, and cosmetic arenas. Its non-dermatological formulations offer solutions for women’s health, pain management, and other markets. The company’s flagship product includes Invisicare, a patented polymer delivery system technology that enhances the delivery of active ingredients for topically applied skin care products. It ... [Read more]

Founded 1998
Employees 2
Stock Exchange OTCMKTS
Ticker Symbol SKVI
Full Company Profile

Financial Performance

In 2024, Skinvisible's revenue was $20,000, a change of 0.00% compared to the previous year's $20,000. Losses were -$565,654, -76.26% less than in 2023.

Financial Statements

News

There is no news available yet.